OTC Pharmaceuticals - G7 | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$76.83bn in 2024. The market is expected to grow annually by 3.50% (CAGR 2024-2029).
The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$17.66bn in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$98.70 are generated in 2024.
In the OTC Pharmaceuticals market, 28.9% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in G7 countries is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in the OTC Pharmaceuticals market have shifted towards self-medication and convenience.

Consumers are increasingly seeking over-the-counter medications for minor ailments and common health issues, as they provide a quick and easy solution without the need for a doctor's prescription. This preference for self-medication is driven by the desire for convenience and cost-effectiveness. Additionally, the aging population in G7 countries has contributed to the growth of the OTC Pharmaceuticals market, as older individuals often require medications for chronic conditions that can be managed with over-the-counter products.

Trends in the market are also driving the growth of the OTC Pharmaceuticals market in G7 countries. One notable trend is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking alternative treatments that are perceived as more natural and holistic.

This trend has led to the emergence of a wide range of herbal and natural OTC Pharmaceuticals products in the market. Another trend is the growing focus on preventive healthcare. Consumers are proactively seeking OTC Pharmaceuticals products that can help them maintain their health and prevent the onset of illnesses.

This trend is particularly prevalent among younger consumers who prioritize wellness and preventive measures. Local special circumstances in G7 countries are also contributing to the growth of the OTC Pharmaceuticals market. One such circumstance is the well-established healthcare infrastructure in these countries.

G7 countries have robust healthcare systems that provide access to quality healthcare services. This, coupled with high levels of health literacy among the population, has created a conducive environment for the growth of the OTC Pharmaceuticals market. Additionally, the regulatory environment in G7 countries is supportive of the OTC Pharmaceuticals market.

These countries have well-defined regulations that ensure the safety and efficacy of over-the-counter medications, giving consumers confidence in purchasing and using these products. Underlying macroeconomic factors are also driving the growth of the OTC Pharmaceuticals market in G7 countries. The strong economic growth in these countries has increased disposable incomes, allowing consumers to spend more on healthcare and wellness products.

Additionally, the rising healthcare costs and increasing burden on healthcare systems have led to a shift towards self-medication and the use of over-the-counter medications as a cost-effective alternative. The favorable economic conditions in G7 countries have created a conducive environment for the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in G7 countries is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

The preference for self-medication, the emergence of natural and herbal remedies, and the focus on preventive healthcare are driving the growth of the market. The well-established healthcare infrastructure, supportive regulatory environment, and strong economic conditions in G7 countries further contribute to the growth of the OTC Pharmaceuticals market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.